Edition:
United Kingdom

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

3.48USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$3.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
268,467
52-wk High
$5.99
52-wk Low
$1.59

Latest Key Developments (Source: Significant Developments)

Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS SECURES DEBT FACILITY WITH MIDCAP FINANCIAL.HTG MOLECULAR DIAGNOSTICS INC - ‍ENTERED INTO A SENIOR DEBT FACILITY WITH MIDCAP FINANCIAL TO REPLACE ITS EXISTING SENIOR CREDIT FACILITY.HTG MOLECULAR DIAGNOSTICS INC - ‍DURATION OF TERM LOAN IS FIVE YEARS, WITH INTEREST ONLY PAYMENTS FOR FIRST TWO YEARS​.HTG MOLECULAR DIAGNOSTICS - ‍SENIOR FACILITY ALSO INCLUDES AN INITIAL $2.0 MILLION REVOLVING LINE OF CREDIT, SECURED BY ACCOUNTS RECEIVABLE AND INVENTORY​.HTG MOLECULAR DIAGNOSTICS INC - ‍REVOLVING LINE OF CREDIT IS EXPANDABLE TO UP TO $10.0 MILLION UNDER CERTAIN CONDITIONS OVER A FIVE-YEAR PERIOD​.HTG MOLECULAR DIAGNOSTICS-UP TO $30.0 MILLION CREDIT FACILITY CONSISTS OF $7.0 MILLION TERM LOAN WITH ABILITY TO ACCESS ANOTHER $13.0 MILLION ADDITIONAL TRANCHE.  Full Article

HTG Molecular Q4 Loss Per Share $0.15
Thursday, 22 Mar 2018 

March 22 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 LOSS PER SHARE $0.15.Q4 REVENUE $7.9 MILLION VERSUS $1.5 MILLION.  Full Article

HTG Molecular Diagnostics Intends To Offer 10 mln shares of common stock
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.HTG MOLECULAR DIAGNOSTICS - ‍INTENDS TO OFFER AND SELL, 10 MILLION SHARES OF COMMON STOCK IN UNDERWRITTEN PUBLIC OFFERING​.  Full Article

HTG Announces Preliminary Q4 And Full Year 2017 Unaudited Financial Results
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - HTG Molecular Diagnostics Inc ::HTG ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 UNAUDITED FINANCIAL RESULTS AND PROVIDES INITIAL 2018 REVENUE GUIDANCE.SEES Q4 2017 REVENUE $6.9 MILLION TO $7.2 MILLION.SEES FY 2017 REVENUE $13.8 MILLION TO $14.1 MILLION.SEES FY 2018 REVENUE $20 MILLION TO $25 MILLION.  Full Article

HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT.HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING.  Full Article

HTG Molecular Diagnostics Expands Its Collaboration With Merck
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY.HTG MOLECULAR - TO DEVELOP CUSTOM PROFILING ASSAY TO SUPPORT BIOMARKER RESEARCH FOR 6 INDICATIONS WITHIN MERCK KGAA'S DRUG DEVELOPMENT PIPELINE.  Full Article

HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master Agreement
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC. 18. CO, UNIT OF QIAGEN, AMENDED FIRST STATEMENT OF WORK UNDER MASTER AGREEMENT - SEC FILING.HTG MOLECULAR DIAGNOSTICS - UNDER AGREEMENT, QIAGEN AGREED TO PAY CO LOW, SINGLE‑DIGIT MILLIONS OF DOLLARS FOR NEXT‑PHASE ACTIVITIES FOR PROJECT.  Full Article

HTG Molecular Diagnostics reports third quarter earnings
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​
Monday, 18 Sep 2017 

Sept 18 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics Inc - ‍HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.60
Tuesday, 8 Aug 2017 

Aug 8 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports second quarter 2017 results.Q2 loss per share $0.60.Q2 revenue $1.8 million.Sees FY 2017 revenue $9.0 million to $12 million.  Full Article

BRIEF-HTG Promotes John Lubniewski To President And Chief Operating Officer

* HTG PROMOTES JOHN LUBNIEWSKI TO PRESIDENT AND CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)